"MAP Kinase Kinase 6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitogen-activated protein kinase kinase with specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES.
| Descriptor ID |
D048669
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.565.600 D08.811.913.696.620.682.725.200.600 D12.644.360.440.600 D12.776.476.440.600
|
| Concept/Terms |
MAP Kinase Kinase 6- MAP Kinase Kinase 6
- Stress-Activated Protein Kinase Kinase-3
- Stress Activated Protein Kinase Kinase 3
- Mitogen-Activated Protein Kinase Kinase 6
- Mitogen Activated Protein Kinase Kinase 6
- MEK6 MAP Kinase Kinase
- MEK6 Protein Kinase
- Protein Kinase, MEK6
- MAP Kinase Kinase MEK6
- SAPKK3 Protein Kinase
- Protein Kinase, SAPKK3
MAP Kinase Kinase 6b- MAP Kinase Kinase 6b
- MEK6b Protein Kinase
- Protein Kinase, MEK6b
- MKK6b Protein Kinase
- Protein Kinase, MKK6b
MAP Kinase Kinase 6c- MAP Kinase Kinase 6c
- MEK6c Protein Kinase
- Protein Kinase, MEK6c
- MKK6c Protein Kinase
- Protein Kinase, MKK6c
|
Below are MeSH descriptors whose meaning is more general than "MAP Kinase Kinase 6".
Below are MeSH descriptors whose meaning is more specific than "MAP Kinase Kinase 6".
This graph shows the total number of publications written about "MAP Kinase Kinase 6" by people in this website by year, and whether "MAP Kinase Kinase 6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MAP Kinase Kinase 6" by people in Profiles.
-
Pin-Pointing the Key Hubs in the IFN-? Pathway Responding to SARS-CoV-2 Infection. Viruses. 2022 09 30; 14(10).
-
A de novo 1.58?Mb deletion, including MAP2K6 and mapping 1.28?Mb upstream to SOX9, identified in a patient with Pierre Robin sequence and osteopenia with multiple fractures. Am J Med Genet A. 2015 Aug; 167A(8):1842-50.
-
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma. 2009 Dec; 50(12):2017-29.
-
The structure of the MAP2K MEK6 reveals an autoinhibitory dimer. Structure. 2009 Jan 14; 17(1):96-104.
-
Identification of a nuclear export signal in MKK6, an activator of the carp p38 mitogen-activated protein kinases. Eur J Biochem. 2000 Jul; 267(14):4362-71.